According to FutureWise analysis, the market for protein sequencing in 2025 is US$ 3.11 billion, and is expected to reach US$ 4.49 billion by 2033 at a CAGR of 3.69%.
The increasing focus of pharmaceutical biotechnology companies on target-based drug development is driving market growth. Advancements in analytical techniques and clinical mass spectrometry are also stimulating market growth. Additionally, increasing financial support from public and private organizations for proteomics, combined with technological advancements in identifying isobaric remnants in protein sequences, is also positively influencing the market.
The protein sequencing market is bifurcated into product and service, technology, application, end-user, and region. In terms of product and service, protein sequencing services are expected to be the market leader. The increasing number of sequencing procedures, alongside technological advancements, remains the key factor driving the demand for protein sequencing products. Reagents and consumables are also expected to experience notable growth due to the increase in sequencing procedures and advancements in protein sequencing technology.
Based on technology, mass spectrometry is expected to witness high growth owing to its benefits, such as identification of modified proteins and cost-efficiency. Prominent players aiming to launch technologically advanced spectrometry instruments are significantly expanding the protein sequencing market size.
In terms of application, biotherapeutics is expected to control the market growth owing to rising antibiotic resistance of microbes and increasing demand for targeted drug therapy. Technological advancements, alongside the benefits of protein sequencing-based methods for drug development, are also positively influencing the market.
The academic institutes and research centers segment is expected to drive the market's growth. Academic institutes and research centres receive hefty funding from public and private organizations for proteomic research. They offer a range of protein sequencing services, including Edman degradation and mass spectrometry. It also addresses the issues of budget constraints and inadequate infrastructure. Owing to these features, there has been a significant growth in academic institutes and research centers, thus propelling the market.
Based on the region, North America is the global leader of the market. Increasing expenditure and research of major biotechnology and pharmaceutical companies is driving the market growth in the region. The growing focus on structure-based drug design, alongside an increase in proteomic research, is boosting the market's presence in the region. The development of protein sequencing data analysis solutions is driving the market's growth in the region.